BioReference Laboratories and Parent Company
Outcome
OIG enforcement action against BioReference Laboratories and Parent Company for false claims. Penalty: $9.8 million.
Details
BioReference Laboratories and Parent Company — OIG Enforcement (2026)
OIG took enforcement action against BioReference Laboratories and Parent Company in 2026 involving false claims violations in the Physician Practices sector.
Penalty: $9.8 million
Violation types: False Claims
Entity type: Physician Practice
Penalty type: Settlement
Source: BioReference Laboratories and Parent Company Agree to Pay $9.85 Million to Resolve False Claims Act Allegations of Illegal Payments to Referring Physicians
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works